PODD
Insulet
Earnings and EPS analysis
- Stocks
- Healthcare
- NASDAQ: PODD
- Earnings
EPS in 2026 (TTM): $5.35
Last Report Period Date: Jun 30, 2026
Currently, PODD's 12-month EPS stands at $5.35, according to the most recent financial reports. During 2025, PODD reported a per-share earnings of $3.51, which shows a decline compared to the EPS of $5.97 recorded in 2024. PODD recorded an EPS of $1.37 for the quarterly period ending on Jun 30, 2026.
PODD earnings history
In 2025, Insulet's earnings per share was $3.51, a decline of 41.2% from $5.97 in 2024. Over the quarter ending Jun 30, 2026, the earnings per share came in at $1.37, reflecting a 328.1% increase compared to the same quarter a year earlier. As of June 2026, the TTM EPS is $5.35. During 2024, the annual earnings per share was $5.97, representing an increase of 101.7% compared to 2023.
PODD EPS vs price chart
PODD EPS growth history
In the past 12 months, Insulet has recorded an earnings per share growth rate of 328.1% (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 268.8% per year. In the last five years, the company had an average annual EPS growth of 99.9%.
PODD Earnings Waterfall
PODD Earnings vs Peers
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| MDT Medtronic Plc | 24.89 | 3.3% | 9.8% | 6.9% |
| PODD Insulet Corporation | 27.69 | -41.2% | 268.8% | 99.9% |
| JNJ Johnson & Johnson | 30.96 | 90.6% | 17.7% | 14.8% |
| DXCM Dexcom Inc | 35.65 | 46.6% | 34.5% | 7.9% |
| ABT Abbott Laboratories | 37.63 | -51.4% | -1.8% | 8.2% |
| LLY Lilly(Eli) & Company | 42.07 | 95.6% | 49.2% | 27.5% |
| ICUI ICU Medical Inc | 152.37 | 100.6% | N/A | -62.7% |
| DCTH Delcath Systems Inc | 1,714 | 108.6% | N/A | N/A |
| TNDM Tandem Diabetes Care Inc | N/A | -106.8% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.